Breaking News Instant updates and real-time market news.

UN

Unilever; also tag UL

$57.96

-0.84 (-1.43%)

, UL

Unilever; also tag UN

$56.81

-0.84 (-1.46%)

10:50
08/10/17
08/10
10:50
08/10/17
10:50

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Unilever (UN, UL) downgraded to Underperform from Sector Perform at RBC Capital with analyst James Edwardes Jones citing valuation and his belief that the company may not meet its 2020 targets. 2. Masonite (DOOR) downgraded to Equal Weight from Overweight at Stephens. 3. Synacor (SYNC) downgraded to Hold from Buy at Craig-Hallum with analyst Jason Kreyer saying he is "unequivocally" disappointed that the AT&T (T)portal launch has not yet monetized at a rate anticipated. 4. NetEase (NTES) downgraded to Underperform from Outperform at CLSA. 5. Achillion (ACHN) downgraded to Neutral from Outperform at Baird with analyst Brian Skorney saying the PNH data reported earlier this week was better than expected but he is not convinced that given the drug's therapeutic window, dosing, and impact on LDH that it can be competitive with Soliris. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

UN

Unilever; also tag UL

$57.96

-0.84 (-1.43%)

UL

Unilever; also tag UN

$56.81

-0.84 (-1.46%)

DOOR

Masonite

$55.88

-16.875 (-23.20%)

SYNC

Synacor

NTES

NetEase

$315.05

5.83 (1.89%)

ACHN

Achillion

$4.81

0.8 (19.95%)

  • 10

    Aug

  • 10

    Aug

  • 14

    Aug

UN Unilever; also tag UL
$57.96

-0.84 (-1.43%)

04/12/17
SUSQ
04/12/17
UPGRADE
Target $132
SUSQ
Positive
PepsiCo upgraded to Positive on M&A potential at Susquehanna
As previously reported, Susquehanna analyst Pablo Zuanic upgraded PepsiCo to Positive from Neutral. He believes Kraft Heinz (KHC) needs to a do another deal following its failed acquisition of Unilever (UL) and feels Pepsi and Mondelez (MDLZ) are the two most likely candidates. Zuanic raised his price target to $132 form $118 on PepsiCo shares.
07/10/17
SUSQ
07/10/17
NO CHANGE
Target $91
SUSQ
Kraft Heinz likely to go hostile in pursuit of Unilever, says Susquehanna
Susquehanna analyst Pablo Zuanic noted that a six-month hiatus required by British takeover law will have passed in the middle of August and he sees the possibility of Kraft Heinz (KHC) coming back with a hostile bid for Unilever (UN) as "more than 75% likely" to happen. A $200B deal could be accretive in the mid-20% range for Kraft shareholders, estimates Zuanic, who cut his price target on Kraft Heinz shares to $91 from $99 to reflect a smaller premium to its peers. He keeps a Neutral rating on the Kraft shares.
08/10/17
RBCM
08/10/17
DOWNGRADE
RBCM
Underperform
Unilever downgraded to Underperform from Sector Perform at RBC Capital
RBC Capital analyst James Edwardes Jones downgraded Unilever based on valuation and his belief that the company may not meet its 2020 targets. Price target to $42 from $45.
05/17/17
JEFF
05/17/17
NO CHANGE
JEFF
Jefferies sees Unilever as interested if Colgate is for sale
After the New York Post reported that Colgate (CL) may be willing to sell for $100 per share, Jefferies analyst Martin Deboo says he'd expect Unilever (UN, UL) to be an interested party. The analyst notes he's argued for some time that Unilever should create a "New World Order" in Household & Personal Care by acquiring Colgate. Such a deal would support his bullish thesis on Unilever shares.
UL Unilever; also tag UN
$56.81

-0.84 (-1.46%)

DOOR Masonite
$55.88

-16.875 (-23.20%)

05/10/17
RBCM
05/10/17
NO CHANGE
RBCM
Masonite should be bought on weakness, says RBC Capital
RBC Capital analyst Robert Wetenhall recommends buying Masonite on weakness after it reported weaker than expected results. The analyst says that the miss was probably caused by "manufacturing inefficiencies" and "inventory adjustments" by large retailers. He expects these issues to "be resolved," and he keeps a $92 price target and Outperform rating on the shares.
08/10/17
08/10/17
DOWNGRADE
Target $89

Equal Weight
Masonite downgraded to Equal Weight at Stephens
As previously reported, Stephens analyst Trey Grooms downgraded Masonite to Equal Weight from Overweight, with $89 price target, after the company's Q2 results came in "significantly" below expectations due to a myriad of issues, most of which he believes could likely continue.
06/16/17
WEDB
06/16/17
INITIATION
WEDB
Outperform
Masonite coverage assumed with an Outperform at Wedbush
Wedbush analyst Jay McCanless assumed coverage of Masonite with an $85 price target and an Outperform rating. The analyst thinks that the company's strategy of focusing on the door market is correct, and he believes that it can meet the midpoints of its EBITDA and EPS guidance ranges.
08/10/17
SPHN
08/10/17
DOWNGRADE
SPHN
Equal Weight
Masonite downgraded to Equal Weight from Overweight at Stephens
SYNC Synacor

06/26/17
CHLM
06/26/17
NO CHANGE
Target $5
CHLM
Buy
AT&T portal ramping earlier than expected for Synacor, says Craig-Hallum
Craig-Hallum analyst George Sutton said Synacor's (SYNC) launch of the AT&T.net (T) portal has ramped up a bit earlier than he'd anticipated and noted that its website metrics suggest it is being well received by users. Sutton, who thinks success from this initiative should lead to a significant acceleration in the third quarter, keeps a Buy rating and $5 price target on Synacor shares.
08/10/17
CHLM
08/10/17
DOWNGRADE
CHLM
Hold
Synacor downgraded to Hold from Buy at Craig-Hallum
08/10/17
08/10/17
DOWNGRADE
Target $4

Hold
Synacor downgraded to Hold at Craig-Hallum
As previously reported, Craig-Hallum analyst Jason Kreyer downgraded Synacor (SYNC) to Hold from Buy saying he is "unequivocally" disappointed that the AT&T (T)portal launch has not yet monetized at a rate anticipated. The monetization engines will be cranked up slower than expected as the team is testing ads to determine how best to monetize the site, a process likely to result in a six month longer ramp than originally expected, he contends. The analyst also lowered his price target on the shares to $4 from $5.
04/18/17
04/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Arconic (ARNC) initiated with a Neutral at JPMorgan. 2. Priceline (PCLN) coverage transferred with an Outperform at Macquarie. 3. Interpublic Group (IPG) was initiated with an Outperform at Evercore ISI while Omnicom (OMC) was initiated with an In Line. 4. Alteryx (AYX) was initiated with an Outperform at William Blair, Raymond James, JMP Securities, and Cowen, an Overweight at Pacific Crest, a Buy at Goldman Sachs, and a Neutral at JPMorgan. 5. Synacor (SYNC) initiated with a Buy on upcoming growth at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
NTES NetEase
$315.05

5.83 (1.89%)

08/10/17
LYON
08/10/17
DOWNGRADE
LYON
Underperform
NetEase downgraded to Underperform from Outperform at CLSA
08/02/17
DAIW
08/02/17
DOWNGRADE
DAIW
Outperform
NetEase downgraded to Outperform from Buy at Daiwa
Daiwa analyst John Choi downgraded NetEase to Outperform from Buy and maintained its $330 price target following a recent ChinaJoy visit that leads him to believe NetEase's second half online game pipeline is relatively weaker compared to Tencent. The analyst also said NetEase faces a high base for second half revenues given the lack of new blockbuster mobile game, ongoing Onmyoji deceleration, and minimal near-term Minecraft revenue.
07/25/17
DBAB
07/25/17
NO CHANGE
Target $343
DBAB
Buy
NetEase price target raised to $343 from $300 at Deutsche Bank
Deutsche Bank analyst Han Joon Kim raised his price target for NetEase to $343 and keeps a Buy rating on the shares. The stock should be bought on any weakness surrounding near-term earnings or Minecraft concerns, Kim tells investors in a research note. He notes that while Minecraft is "off to a rocky start," his constructive view on the shares extends beyond individual games.
06/07/17
STPT
06/07/17
DOWNGRADE
STPT
Reduce
NetEase downgraded to Reduce from Buy at Standpoint Research
ACHN Achillion
$4.81

0.8 (19.95%)

08/10/17
MAXM
08/10/17
NO CHANGE
Target $7
MAXM
Buy
Achillion price target raised to $7 from $5 at Maxim
Maxim analyst Jason Kolbert is introducing estimates for paroxysmal nocturnal hemoglobinuria in his model for Achillion after the company reported "proof of concept" news for its Factor D program. Adding in the potential for an eventual PHH indication leads him to raise his price target on Achillion shares to $7 from $5. He keeps a Buy rating on the stock.
08/10/17
BARD
08/10/17
DOWNGRADE
Target $5
BARD
Neutral
Achillion downgraded to Neutral at Baird
As reported previously, Baird analyst Brian Skorney downgraded Achillion to Neutral from Outperform. He said the PNH data reported earlier this week was better than expected but he is not convinced that given the drug's therapeutic window, dosing, and impact on LDH that it can be competitive with Soliris. Skorney maintained his $5 price target on Achillion shares.
08/10/17
BARD
08/10/17
DOWNGRADE
BARD
Neutral
Achillion downgraded to Neutral from Outperform at Baird
05/18/17
LEER
05/18/17
UPGRADE
Target $6
LEER
Outperform
Achillion upgraded to Outperform from Market Perform at Leerink
Leerink analyst Joseph Schwartz upgraded Achillion Pharmaceuticals (ACHN) and raised his price target for the shares to $6 from $4. The analyst sees limited downside from current share levels even if the complement study fails, assuming the hepatitis C virus partnership with Johnson & Johnson (JNJ) remains intact. Schwartz assigned a "conservative" 33% probability of success to Achillion's complement program due to the lack of precedent for an oral small molecule inhibitor of complement factor D that is selective enough to avoid off target effects. He believes risks to successful ACH-4471 development are fully discounted in Achillion's current stock price.

TODAY'S FREE FLY STORIES

10:30
11/23/17
11/23
10:30
11/23/17
10:30
General news
FX Action: EUR-USD, USD-JPY and other major pairings are in sideways mode »

FX Action: EUR-USD,…

DE

Deere

$145.25

6.02 (4.32%)

09:53
11/23/17
11/23
09:53
11/23/17
09:53
Upgrade
Deutsche Bank gets off sidelines, upgrades Deere shares to Buy »

Deutsche Bank analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

08:55
11/23/17
11/23
08:55
11/23/17
08:55
General news
FX Update: USD-CAD vaulted upwards on weak Canadian data »

FX Update: USD-CAD…

08:30
11/23/17
11/23
08:30
11/23/17
08:30
General news
FX Action: The USD index (DXY) logged a one-month low »

FX Action: The USD index…

TSLA

Tesla

$312.60

-5.21 (-1.64%)

08:08
11/23/17
11/23
08:08
11/23/17
08:08
Hot Stocks
Tesla CEO highlights 'record time' on Australian ion battery »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

TSLA

Tesla

$312.60

-5.21 (-1.64%)

08:07
11/23/17
11/23
08:07
11/23/17
08:07
Hot Stocks
Tesla completes construction on largest lithium ion battery in Australia »

The South Australian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

GSK

GlaxoSmithKline

$35.06

0.25 (0.72%)

, INVA

Innoviva

$13.42

0.01 (0.07%)

07:56
11/23/17
11/23
07:56
11/23/17
07:56
Hot Stocks
GSK, Innoviva submit data to FDA for expanded Trelegy Ellipta label »

GlaxoSmithKline (GSK) and…

GSK

GlaxoSmithKline

$35.06

0.25 (0.72%)

INVA

Innoviva

$13.42

0.01 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVM

Silvercorp Metals

$2.51

-0.07 (-2.71%)

07:52
11/23/17
11/23
07:52
11/23/17
07:52
Hot Stocks
Silvercorp Metals to buy back up to 5% of shares »

Silvercorp Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEL

Cellcom Israel

$10.00

-0.1 (-0.99%)

07:49
11/23/17
11/23
07:49
11/23/17
07:49
Hot Stocks
Cellcom Israel now second layer company according to Concentration Law »

Cellcom Israel announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GASS

StealthGas

$4.07

0.36 (9.70%)

07:06
11/23/17
11/23
07:06
11/23/17
07:06
Recommendations
StealthGas analyst commentary at Jefferies »

StealthGas trades at only…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$41.01

4.31 (11.74%)

07:02
11/23/17
11/23
07:02
11/23/17
07:02
Recommendations
Copart analyst commentary at Jefferies »

Copart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DE

Deere

$145.25

6.02 (4.32%)

06:56
11/23/17
11/23
06:56
11/23/17
06:56
Upgrade
Deere rating change at Deutsche Bank »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DE

Deere

$145.25

6.02 (4.32%)

06:55
11/23/17
11/23
06:55
11/23/17
06:55
Recommendations
Deere analyst commentary at Wells Fargo »

Deere price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

06:40
11/23/17
11/23
06:40
11/23/17
06:40
General news
FX Update: The dollar has remained on a weakening track »

FX Update: The dollar has…

SECO

Seeco Holding

$8.34

0.14 (1.71%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
Seeco Holding management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
Deutsche Bank to hold a conference »

Thailand SET Corporate…

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
RBC Capital to hold field trip »

European Utilities Field…

BASFY

BASF

$27.39

-0.13 (-0.47%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
BASF management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

  • 24

    Nov

RBS

RBS

$7.30

-0.04 (-0.54%)

04:55
11/23/17
11/23
04:55
11/23/17
04:55
Conference/Events
RBS management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Nov

  • 24

    Nov

04:25
11/23/17
11/23
04:25
11/23/17
04:25
General news
FX Action: USD-CAD punched out a 10-day low »

FX Action: USD-CAD…

02:35
11/23/17
11/23
02:35
11/23/17
02:35
General news
FX Update: The dollar has remained on a downward path »

FX Update: The dollar…

L

Loews

$49.36

-0.02 (-0.04%)

, GE

General Electric

$18.15

0.32 (1.79%)

18:41
11/22/17
11/22
18:41
11/22/17
18:41
Hot Stocks
Loews CEO James Tisch buys 3M shares of General Electric »

In a regulatory filing,…

L

Loews

$49.36

-0.02 (-0.04%)

GE

General Electric

$18.15

0.32 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRFS

BRF S.A.

$12.77

-0.16 (-1.24%)

18:06
11/22/17
11/22
18:06
11/22/17
18:06
Hot Stocks
BRF S.A. names Jose Aurelio Drummond Jr. as CEO »

BRF S.A. hereby informs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$35.42

0.2 (0.57%)

18:02
11/22/17
11/22
18:02
11/22/17
18:02
Hot Stocks
Suncor closes sale of equity interest in East Tan Farm, redeems $750M in debt »

Suncor successfully…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SAP

SAP

$113.85

-1.44 (-1.25%)

17:53
11/22/17
11/22
17:53
11/22/17
17:53
Periodicals
SAP launches investigation of sales practices in Gulf region, Reuters reports »

SAP has launched a formal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.